Effects of a muscarinic type-2 antagonist on cardiorespiratory function and intestinal transit in horses anesthetized with halothane and xylazine

American Journal of Veterinary Research

Volumn 65, Issue 4, 2004, Pages 464-472

  Teixeira Neto, Francisco J ^a,b   McDonell, Wayne N ^a   Black, William D ^a   Moraes, Aury N ^a   Duronghphongtorn, Sumit ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM DERIVATIVE; HALOTHANE; HEMOGLOBIN; KETALEAN; KETAMINE; METHOCTRAMINE; MUSCARINIC M2 RECEPTOR ANTAGONIST; OXYGEN; SODIUM CHLORIDE; XYLAZINE;

ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; ARTIFICIAL VENTILATION; AUSCULTATION; BRADYCARDIA; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR FUNCTION; CHRONOTROPISM; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; DRUG SELECTIVITY; FEMALE; HEART OUTPUT; HEART RATE; HORSE; INTESTINE MOTILITY; INTESTINE TRANSIT TIME; INTRAOPERATIVE PERIOD; MALE; MONITORING; NONHUMAN; RANDOMIZATION; RESPIRATORY FUNCTION; SCORING SYSTEM; TISSUE OXYGENATION;

ANESTHESIA, GENERAL; ANESTHETICS, COMBINED; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; DIAMINES; GASTROINTESTINAL TRANSIT; HALOTHANE; HEART RATE; HEMOGLOBINOMETRY; HORSES; MUSCARINIC ANTAGONISTS; STROKE VOLUME; XYLAZINE;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 1842431801     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.464     Document Type: Article

References (50)

1. Ilkiw JE, Pascoe PJ, Haskins SC, et al. The cardiovascular sparing effect of fentanyl and atropine, administered to enflurane anesthetized dogs. Can J Vet Res 1994;58:248-253.
2. Singh S, McDonell WN, Young SS, et al. Cardiopulmonary and gastrointestinal effects of xylazine/ketamine-induced anesthesia in horses previously treated with glycopyrrolate. Am J Vet Res 1996; 57:1762-1770.
3. Brown JH, Taylor P. Muscarinic receptor agonists and antagonists. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill Book Co, 2001;155-173.
4. Gasthuys F, De Moor A, Parmentier D. Haemodynamic changes during sedation in ponies. Vet Res Commun 1990;14:309-327.
5. Wagner AE, Muir WW 3rd, Hinchcliff KW. Cardiovascular effects of xylazine and detomidine in horses. Am J Vet Res 1991; 52:651-657.
6. Singh S, Young SS, McDonell WN, et al. Modification of cardiopulmonary and intestinal motility effects of xylazine with glycopyrrolate in horses. Can J Vet Res 1997;61:99-107.
7. Short CE, Rebhun WC. Complications caused by the oculocardiac reflex during anesthesia in a foal. J Am Vet Med Assoc 1980; 176:630-631.
8. Dyson DH, James-Davies R. Dose effect and benefits of glycopyrrolate in the treatment of bradycardia in anesthetized dogs. Can Vet J 1999;40:327-331.
9. Ducharme NG, Fubini SL. Gastrointestinal complications associated with the use of atropine in horses. J Am Vet Med Assoc 1983; 182:229-231.
10. Adams SB, Lamar CH, Masty J. Motility of the distal portion of the jejunum and pelvic flexure in ponies: Effects of six drugs. Am J Vet Res 1984;45:795-799.
11. Roberts MC, Argenzio A. Effects of amitraz, several opiate derivatives and anticholinergic agents on intestinal transit in ponies. Equine Vet J 1986;18:256-260.
12. Singh S, McDonell WN, Young SS, et al. The effect of glycopyrrolate on heart rate and intestinal motility in conscious horses. J Vet Anaesth 1997;24:14-19.
13. Teixeira Neto FJ, McDonell WN, Black WD, et al. Effects of glycopyrrolate on cardiorespiratory function in horses anesthetized with halothane and xylazine. Am J Vet Res 2004;65:456-463.
14. Goyal RK. Muscarinic receptor subtypes. N Engl J Med 1989; 321:1022-1029.
15. Deighton NM, Motomura S, Borquez D, et al. Muscarinic cholinoceptors in the human heart: Demonstration, subclassification, and distribution. Naunyn Schmiedebergs Arch Pharmacol 1990; 341:14-21.
16. Schulte B, Volz-Zang C, Mutschler E, et al. AF-DX 116, a cardioselective muscarinic antagonist in humans: Pharmacodynamic and pharmacokinetic properties. Clin Pharmacol Ther 1991;50:372-378.
17. de Ponti F, Einaudi A, Cosentino M, et al. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog. J Pharmacol Exp Ther 1993;264:789-794.
18. Hendrix PK, Robinson EP. Effects of a selective and a nonselective muscarinic cholinergic antagonist on heart rate and intestinal motility in dogs. J Vet Pharmacol Ther 1997;20:387-395.
19. Sasaki S, Motomura S. Comparison of anti-M2-muscarinic effect of AF-DX 116 on atrioventricular nodal conduction with those of pirenzepine and atropine as antibradyarrhythmic drugs. J Cardiovasc Pharmacol 1999;33:912-921.
20. Eglen RM, Adham N, Whiting RL. Acute desensitization of muscarinic receptors in the isolated guinea-pig ileal longitudinal muscle. J Auton Pharmacol 1992;12:137-148.
21. Lin S, Kajimura M, Takeuchi K, et al. Expression of muscarinic receptor subtypes in rat gastric smooth muscle: Effect of M3 selective antagonist on gastric motility and emptying. Dig Dis Sci 1997; 42:907-914.
22. Micheletti R, Montagna E, Giachetti A. AF-DX 116, a cardioselective muscarinic antagonist. J Pharmacol Exp Ther 1987; 241:628-634.
23. Melchiorre C, Angeli P, Lambrecht G, et al. Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine. Eur J Pharmacol 1987;144:117-124.
24. Hendrix PK, Robinson EP, Raffe MR. Methoctramine, a cardioselective muscarinic cholinergic antagonist, prevents fentanyl-induced bradycardia in the dog. J Vet Pharmacol Ther 1995;18:87-93.
25. Alexander F. The effect of some anti-diarrhoeal drugs on intestinal transit and faecal excretion of water and electrolytes in the horse. Equine Vet J 1978;10:229-234.
26. Wagner AE, Bednarski RM, Muir WW 3rd. Hemodynamic effects of carbon dioxide during intermittent positive-pressure ventilation in horses. Am J Vet Res 1990;51:1922-1929.
27. Khanna AK, McDonell WN, Dyson DH, et al. Cardiopulmonary effects of hypercapnia during controlled intermittent positive pressure ventilation in the horse. Can J Vet Res 1995; 59:213-221.
28. Antonaccio MJ, Robson RD, Kerwin L. Evidence for increased vagal tone and enhancement of baroreceptor reflex activity after xylazine (2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazine) in anesthetized dogs. Eur J Pharmacol 1973;23:311-316.
29. Savola JM. Cardiovascular actions of detomidine. Acta Vet Scand Suppl 1986;82:47-57.
30. Thurmon JC, Tranquilli WJ, Benson GJ. Preanesthetics and anesthetic adjuncts. In: Thurmon JC, Tranquilli WJ, Benson GJ, eds. Lumb and Jones' veterinary anesthesia. 2nd ed. Baltimore: The Williams & Wilkins Co, 1996;183-209.
31. Garcia-Villar R, Toutain PL, Alvinerie M, et al. The pharmacokinetics of xylazine hydrochloride: An interspecific study. J Vet Pharmacol Ther 1981;4:87-92.
32. Salonen JS, Vaha-Vahe T, Vainio O, et al. Single-dose pharmacokinetics of detomidine in the horse and cow. J Vet Pharmacol Ther 1989;12:65-72.
33. Kollias-Baker CA, Court MH, Williams LL. influence of yohimbine and tolazoline on the cardiovascular, respiratory, and sedative effects of xylazine in the horse. J Vet Pharmacol Ther 1993;16:350-358.
34. Lawson LW, Meyer DJ. Autonomic nervous system: Physiology and pharmacology. In: Barash PG, Cullen BF, Stoelting RK, eds. Clinical anesthesia. 2nd ed. Philadelphia: Lippincott-Raven, 1996; 243-309.
35. Bettschart-Wolfensberger R, Bettschart RW, Vainio O, et al. Cardiopulmonary effects of a 2 hour infusion or medetomidine and its reversal by atipamezole in horses and ponies. J Vet Anaesth 1999;26:8-12.
36. Stoelting RK. Systemic circulation. In: Stoelting RK, ed. Pharmacology and physiology in anesthetic practice. 3rd ed. Philadelphia: Lippincott-Raven, 1999;634-648.
37. Wessale JL, Voelz MB, Geddes LA. Stroke volume and the three phase cardiac output rate relationship with ventricular pacing. Pacing Clin Electrophysiol 1990;13:673-680.
38. Ten Berge RE, Krikke M, Teisman AC, et al. Dysfunctional muscarinic M2 autoreceptors in vagally induced bronchoconstriction of conscious guinea pigs after the early allergic reaction. Eur J Pharmacol 1996;318:131-139.
39. Matsumoto S. Low frequency-dependent mechanism of the M2 receptor function on vagally mediated bronchoconstriction in rabbits in vivo. Life Sci 1999;65:103-112.
40. Aas P, MacLagan J. Evidence for prejunctional M2 muscarinic receptors in pulmonary cholinergic nerves in the rat. Br J Pharmacol 1990;101:73-76.
41. Dabareiner RM, White NA. Large colon impaction in horses: 147 cases (1985-1991). J Am Vet Med Assoc 1995;206:679-685.
42. Little D, Redding WR, Blikslager AT. Risk factors for reduced postoperative fecal output in horses: 37 cases (1997-1998). J Am Vet Med Assoc 2001;218:414-420.
43. Raekallio M, Taylor PM, Bennett RC. Preliminary investigations of pain and analgesia assessment in horses administered phenylbutazone or placebo after arthroscopic gurgery. Vet Surg 1997;26:150-155.
44. Lester GD, Bolton JR, Cullen LK, et al. Effects of general anesthesia on myoelectric activity of the intestine in horses. Am J Vet Res 1992;53:1553-1557.
45. Shen KZ, Barajas-Lopez C, Surprenant A. Functional characterization of neuronal pre and postsynaptic alpha2-adrenoceptor subtypes in guinea-pig submucosal plexus. Br J Pharmacol 1990; 101:925-931.
46. Blandizzi C, Doda M, Tarkovacs G, et al. Functional evidence that acetylcholine release from Auerbach's plexus of guinea-pig ileum is modulated by alpha 2A-adrenoceptor subtype. Eur J Pharmacol 1991;205:311-313.
47. Davies JV, Gerring EL. Effect of spasmolytic analgesic drugs on the motility patterns of the equine small intestine. Res Vet Sci 1983; 34:334-339.
48. Marques JA, Teixeira Neto FJ, Campebell RC, et al. Effects of hyoscine-N-butylbromide given before romifidine in horses. Vet Rec 1998;142:166-168.
49. Geimer TR, Ekstrom PM, Ludders; JW, et al. Haemodynamic effects of hyoscine-N-butilbromide in ponies. J Vet Pharmacol Ther 1995; 18:13-16.
50. Herdt T. Movements of the gastrointestinal tract. In: Cunningham JG, ed. Textbook of veterinary physiology. 2nd ed. Philadelphia: WB Saunders Co, 1997;273-289.